Related Experiment Video
Updated: Mar 8, 2026

06:43
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
14.7K
Large Artery Atherosclerotic Occlusive Disease
Summary
Identifying the cause of ischemic stroke from large artery atherosclerosis is challenging. Optimal treatment focuses on risk factor management and timely revascularization for symptomatic carotid stenosis to prevent future strokes.
Area of Science:
- Neurology
- Vascular Medicine
- Cardiology
Background:
- Large artery atherosclerosis (extracranial or intracranial) is a common cause of ischemic stroke and transient ischemic attack.
- Differentiating causative atherosclerotic lesions from incidental findings is clinically challenging.
- A structured approach is needed for evaluating and treating patients with large artery atherosclerosis.
Observation:
- Four clinical scenarios exist: asymptomatic/symptomatic extracranial carotid stenosis, intracranial atherosclerosis, and extracranial vertebral artery disease.
- Intensive medical therapy is effective for asymptomatic carotid stenosis.
- Severe symptomatic carotid stenosis warrants prompt revascularization, with endarterectomy often preferred over stenting, especially in older women.
Findings:
- Carotid endarterectomy shows lower stroke/death risk than stenting for symptomatic carotid stenosis.
- Older patients and women face higher risks with carotid stenting.
- Continuous risk factor optimization is crucial for preventing stroke in intracranial and vertebral artery atherosclerosis.
Implications:
- Lifelong risk factor management (behavioral changes, intensive medical therapy) is key for stroke prevention.
- Revascularization decisions for carotid stenosis must weigh patient factors and procedural risks.
- A systematic framework aids clinicians in managing large artery atherosclerosis to minimize stroke recurrence.
Related Concept Videos
Atherosclerosis I: Introduction
1.7K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
Peripheral Artery Disease I: Introduction
519
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
519
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
675
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
675
Coronary Artery Disease I: Introduction
1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Coronary Artery Disease II: Pathophysiology
851
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
851
Atherosclerosis III: Management
540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540

